Hutch News

Suppressing immunity to fight HIV infection

Suppressing immunity to fight HIV infection

From the Jerome lab, Vaccine and Infectious Disease Division
Science Spotlight - November 16, 2020
Targeting a subset of stem cells shows lasting, therapeutically relevant gene editing in blood cells

Targeting a subset of stem cells shows lasting, therapeutically relevant gene editing in blood cells

A new Science Translational Medicine paper is first to report how editing a portion of stem cells with CRISPR/Cas9 is sufficient for long-term reactivation of therapeutic hemoglobin
News Releases - July 31, 2019
Engineering B cells to bypass vaccines

Engineering B cells to bypass vaccines

From the Taylor Lab, Vaccine and Infectious Disease Division
Science Spotlight - July 15, 2019
Special delivery: Gold nanoparticles ship CRISPR cargo

Special delivery: Gold nanoparticles ship CRISPR cargo

Fred Hutch scientists used their new golden courier to edit genes tied to HIV, genetic blood disorders
Hutch News - May 27, 2019
Could gold be the key to making gene therapy for HIV and other blood disorders more accessible?

Could gold be the key to making gene therapy for HIV and other blood disorders more accessible?

A proof-of-principle study published in Nature Materials shows that gold nanoparticles loaded with CRISPR and other gene-editing tools safely and effectively edited blood stem cells. (Photos, diagram available for media use.)
News Releases - May 27, 2019
Q&A: A new focus on small cell lung cancer

Q&A: A new focus on small cell lung cancer

Dr. David MacPherson discusses the state of small cell lung cancer research, how his lab is tackling this deadly disease, and what makes him excited for the future
Hutch News - February 07, 2019